Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Stratification of biological therapies by pathobiology in biologic-naive patients with rheumatoid arthritis (STRAP and STRAP-EU): two parallel, open-label, biopsy-driven, randomised trials.

Autor: Rivellese F; Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Queen Mary University of London, London, UK; Barts Health NHS Trust and Barts Biomedical Research Centre, National Institute for Health and Care Research (NIHR), London, UK., Nerviani A; Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Queen Mary University of London, London, UK; Barts Health NHS Trust and Barts Biomedical Research Centre, National Institute for Health and Care Research (NIHR), London, UK., Giorli G; Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Queen Mary University of London, London, UK., Warren L; Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Queen Mary University of London, London, UK., Jaworska E; Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Queen Mary University of London, London, UK., Bombardieri M; Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Queen Mary University of London, London, UK; Barts Health NHS Trust and Barts Biomedical Research Centre, National Institute for Health and Care Research (NIHR), London, UK., Lewis MJ; Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Queen Mary University of London, London, UK; Barts Health NHS Trust and Barts Biomedical Research Centre, National Institute for Health and Care Research (NIHR), London, UK., Humby F; Barts Health NHS Trust and Barts Biomedical Research Centre, National Institute for Health and Care Research (NIHR), London, UK; Rheumatology Department, Guy's and St Thomas' NHS Foundation Trust, London, UK., Pratt AG; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK; Directorate of Musculoskeletal Services, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK., Filer A; Rheumatology Research Group, Institute for Inflammation and Ageing, NIHR Birmingham Biomedical Research Centre and Clinical Research Facility, University of Birmingham, Queen Elizabeth Hospital, Birmingham, UK., Gendi N; Basildon University Hospital, Basildon and Thurrock University NHS Hospitals Foundation Trust, Basildon, UK., Cauli A; Rheumatology Unit, AOU and University of Cagliari, Monserrato, Italy; UOC of Radiology, Ospedale SS Trinità, ATS Cagliari, Italy., Choy E; CREATE Centre, Cardiff University, Cardiff, UK; Department of Rheumatology, University Hospital of Wales, Cardiff, UK., McInnes I; Glasgow Clinical Research Facility, Glasgow Royal Infirmary, Glasgow, UK., Durez P; Institute of Experimental and Clinical Research, Université Catholique de Louvain, Brussels, Belgium; Department of Rheumatology, Cliniques Universitaires Saint-Luc, Brussels, Belgium., Edwards CJ; NIHR Southampton Clinical Research Facility, University Hospital Southampton, Southampton, UK; Faculty of Medicine, University of Southampton, Southampton, UK., Buch MH; Centre for Musculoskeletal Research, Division of Musculoskeletal and Dermatological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK; NIHR Manchester Biomedical Research Centre, Manchester, UK., Gremese E; Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy., Taylor PC; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Botnar Research Centre, University of Oxford, Oxford, UK., Ng N; Rheumatology Department, Guy's and St Thomas' NHS Foundation Trust, London, UK., Cañete JD; Rheumatology Department, Hospital Clínic de Barcelona, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pí I Sunyer, Barcelona, Spain., Raizada S; New Cross Hospital and Cannock Chase Hospital, Royal Wolverhampton NHS Trust, Wolverhampton, UK., McKay ND; Edinburgh Rheumatology Research Group and Rheumatic Diseases Unit, NHS Lothian, Edinburgh, UK., Jadon D; Department of Medicine, University of Cambridge, Cambridge, UK., Sainaghi PP; Department of Rheumatology, University Eastern Piedmont and Maggiore della Carita Hospital, Novara, Italy., Stratton R; Royal Free Hospital, Royal Free London NHS Foundation Trust, London, UK., Ehrenstein MR; Department of Rheumatology, University College London, London, UK., Ho P; The Kellgren Centre for Rheumatology, Manchester Royal Infirmary, Manchester University NHS Foundation Trust, Manchester, UK., Pereira JP; Rheumatology Department, Hospital De Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal; Rheumatology Research Unit, Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal., Dasgupta B; Rheumatology Department, Mid and South Essex University Hospitals NHS Foundation Trust, Southend University Hospital, Westcliff-on-Sea, UK., Gorman C; Department of Rheumatology, Homerton University Hospital, Homerton Healthcare NHS Foundation Trust, London, UK., Galloway J; King's College Hospital, King's College Hospital NHS Foundation Trust, London, UK., Chinoy H; Centre for Musculoskeletal Research, Division of Musculoskeletal and Dermatological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK; Department of Rheumatology, Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust, Manchester Academic Health Science Centre, Salford, UK., van der Heijde D; Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands., Sasieni P; King's Clinical Trials Unit, Kings College London, London, UK., Barton A; Centre for Musculoskeletal Research, Division of Musculoskeletal and Dermatological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK., Pitzalis C; Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Queen Mary University of London, London, UK; Barts Health NHS Trust and Barts Biomedical Research Centre, National Institute for Health and Care Research (NIHR), London, UK; IRCCS Humanitas Research Hospital, Milan, Italy. Electronic address: c.pitzalis@qmul.ac.uk.

Publikováno v: The Lancet. Rheumatology [Lancet Rheumatol] 2023 Nov; Vol. 5 (11), pp. e648-e659.

Scottish rheumatology sonography course: five-year experience of delivering a mentorship-model rheumatology ultrasound training programme accredited by the consortium for the accreditation of sonographic education.

Autor: Ciechomska A; Consultant Rheumatologist, Wishaw General Hospital, NHS Lanarkshire, UK.; Scottish Rheumatology Ultrasound Group., McKay ND; Scottish Rheumatology Ultrasound Group.; Consultant Rheumatologist, Western General Hospital, Lothian Rheumatic Diseases Unit, NHS Lothian, UK., Newcombe L; Lecturer in Podiatry, Glasgow Caledonian University, School of Health and Life Sciences, UK., Brandon M; Scottish Rheumatology Ultrasound Group.; Consultant Physiotherapist, Glasgow Royal Infirmary, Centre for Rheumatic Diseases, NHS Greater Glasgow and Clyde, UK., Youssef H; Scottish Rheumatology Ultrasound Group.; Consultant Rheumatologist, Aberdeen Royal Infirmary, NHS Grampian, UK., Platt P; Consultant Rheumatologist, Northumbria Healthcare NHS Foundation Trust, UK., Dale J; Consultant Rheumatologist, Wishaw General Hospital, NHS Lanarkshire, UK.; Scottish Rheumatology Ultrasound Group., Dickson DM; Senior Lecturer in Diagnostic Imaging, Glasgow Caledonian University, School of Health and Life Sciences, UK.

Publikováno v: Scottish medical journal [Scott Med J] 2021 May; Vol. 66 (2), pp. 51-57.

Efficacy and safety of subcutaneous tocilizumab in rheumatoid arthritis over 1 year: a UK real-world, open-label study.

Autor: Isaacs JD; Arthritis Research UK Experimental Arthritis Treatment Centre, Institute of Cellular Medicine, Newcastle University, Newcastle-upon-Tyne.; Musculoskeletal Unit, Newcastle-upon-Tyne Hospitals NHS Foundation Trust, Newcastle-upon-Tyne., Salih A; Warrington and Halton Hospitals NHS Foundation Trust, Warrington Hospital, Warrington., Sheeran T; Rheumatology Centre, Cannock Chase Hospital, Cannock., Patel YI; Department of Rheumatology, Hull Royal Infirmary, Hull., Douglas K; Department of Rheumatology, Dudley Group NHS Foundation Trust, Dudley., McKay ND; Rheumatic Diseases Unit, Western General Hospital, Edinburgh., Naisbett-Groet B; Roche Products Ltd, Welwyn Garden City., Choy E; CREATE Centre, Division of Infection and Immunity, Cardiff University, Cardiff, UK.

Publikováno v: Rheumatology advances in practice [Rheumatol Adv Pract] 2019 Apr 19; Vol. 3 (1), pp. rkz010. Date of Electronic Publication: 2019 Apr 19 (Print Publication: 2019).

Novel photoplethysmography cardiovascular assessments in patients with Raynaud's phenomenon and systemic sclerosis: a pilot study.

Autor: McKay ND; Department of Rheumatology, Freeman Hospital, Newcastle upon Tyne, Lothian Rheumatic Diseases Unit, Western General Hospital, Edinburgh, Department of Microvascular Diagnostics, Freeman Hospital and Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK. Department of Rheumatology, Freeman Hospital, Newcastle upon Tyne, Lothian Rheumatic Diseases Unit, Western General Hospital, Edinburgh, Department of Microvascular Diagnostics, Freeman Hospital and Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK., Griffiths B; Department of Rheumatology, Freeman Hospital, Newcastle upon Tyne, Lothian Rheumatic Diseases Unit, Western General Hospital, Edinburgh, Department of Microvascular Diagnostics, Freeman Hospital and Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK., Di Maria C; Department of Rheumatology, Freeman Hospital, Newcastle upon Tyne, Lothian Rheumatic Diseases Unit, Western General Hospital, Edinburgh, Department of Microvascular Diagnostics, Freeman Hospital and Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK. Department of Rheumatology, Freeman Hospital, Newcastle upon Tyne, Lothian Rheumatic Diseases Unit, Western General Hospital, Edinburgh, Department of Microvascular Diagnostics, Freeman Hospital and Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK., Hedley S; Department of Rheumatology, Freeman Hospital, Newcastle upon Tyne, Lothian Rheumatic Diseases Unit, Western General Hospital, Edinburgh, Department of Microvascular Diagnostics, Freeman Hospital and Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK., Murray A; Department of Rheumatology, Freeman Hospital, Newcastle upon Tyne, Lothian Rheumatic Diseases Unit, Western General Hospital, Edinburgh, Department of Microvascular Diagnostics, Freeman Hospital and Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK. Department of Rheumatology, Freeman Hospital, Newcastle upon Tyne, Lothian Rheumatic Diseases Unit, Western General Hospital, Edinburgh, Department of Microvascular Diagnostics, Freeman Hospital and Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK., Allen J; Department of Rheumatology, Freeman Hospital, Newcastle upon Tyne, Lothian Rheumatic Diseases Unit, Western General Hospital, Edinburgh, Department of Microvascular Diagnostics, Freeman Hospital and Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK. Department of Rheumatology, Freeman Hospital, Newcastle upon Tyne, Lothian Rheumatic Diseases Unit, Western General Hospital, Edinburgh, Department of Microvascular Diagnostics, Freeman Hospital and Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK. john.allen@nuth.nhs.uk.

Publikováno v: Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2014 Oct; Vol. 53 (10), pp. 1855-63. Date of Electronic Publication: 2014 May 21.